
TSE:SLF
This summary was created by AI, based on 8 opinions in the last 12 months.
Sun Life Financial Inc. (SLF) has seen a recent rally, benefiting from its exposure to the money management sector and long-lived liabilities, particularly in a falling interest rate environment. However, experts express caution over its venture into private credit, a domain that has faced some losses. Compared to Canadian banks, SLF is trading at a lower price-to-earnings ratio, but growth appears modest, particularly in sectors like dental in the U.S. and asset management in Canada. Despite past challenges relative to peers like Manulife Financial, experts indicate that SLF remains a solid long-term investment, bolstered by positive changes and strong returns on equity. Overall, experts are divided, with some seeing it as a steady hold, while others suggest a more cautious approach until clearer signals emerge.
Chart is definitely scary and looking like it is getting ahead of itself but had a big beat last quarter on lower capital review charges. Core results have been great for a long time. Just sold their US annuity business, which de-risks the balance sheet. Deployed some assets in Malaysia, which is a very high growth market for them, a signal to investors that they are ready to grow by acquisition again. Trading at around 1.3X Book, pricier than Manulife (MLF-T) so there is probably better value in Manulife but people are going into this one because of the higher dividend. (See Top Picks.)
One of the issues with the insurance companies is that they are trading at very low multiples and pay great dividend, which they can continue to do but interest rates really affect these companies. He believes that interest rates will stay low. If you have a 3-5 year time horizon, it would make sense to own this.
Over the last couple of years the lifecos, particularly this one and Manulife (MFC-T) have done more to de-risk their balance sheets and change their product mix. Feels these companies are in relatively good shape, provided we are in a recovery. If we head back into a deep recession, there could be some downside. (See Top Picks.)
When they reduce their exposure to the risks, interest rates and the risk in stock prices, then the life companies can do very well. Today’s action by them was a major move to reduce risks in the US, by selling the annuity business. This will cost them $.22 next year in earnings and takes about $1 billion off of BV. Some people were disappointed but he took the opposite view.
Has been hitting 52-week highs lately. Low interest rates have been a problem for lifecos. Had thought 6 months ago that interest rate were likely to pop up but he is now forecasting that slow growth will be staying with us along with low interest rates. Well-run company. Feels the dividend is safe.
All lifecos were trading lower than BV, which is a pretty good sign for a value investor. Ranks very high in his Mark model. Have to start growing their BV now. Really tapered off their exposure to equities. Equities have done extremely well in the last 6 months but they’re not going to get the same bang for their buck as they once did. We now need interest rates to rise. Would prefer it at around $27.